RELITECT
Relitect is developing a novel assay platform for the label free electrochemical detection of binding events. The company's proprietary technology can be applied for high sensitivity, multiplexed diagnostic and life science research products.
RELITECT
Industry:
Biotechnology Health Diagnostics
Founded:
2014-01-01
Address:
Glasgow, Glasgow City, United Kingdom
Country:
United Kingdom
Website Url:
http://www.relitect.com
Total Employee:
11+
Status:
Closed
Total Funding:
750 K GBP
Technology used in webpage:
OpenResty Encryption Everywhere DNS.COM Sharktech Shark Tech
Similar Organizations
Applied Proteomics
Applied Proteomics offers a protein biomarker discovery platform to advance the application of proteomics.
Clinical Genomics Technologies
Clinical Genomics develops innovative products for colorectal cancer diagnosis.
Molecular Health
Molecular Health offers software solutions for evidence-based healthcare decision support and smarter drug development.
Current Employees Featured
Founder
Investors List
Scottish Enterprise
Scottish Enterprise investment in Seed Round - Relitect
IP Group
IP Group investment in Seed Round - Relitect